Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Propofol × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 5 Gastrointestinal 2 Breast 2 Thoracic 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Ovarian Neoplasms 2 Uterine Neoplasms 1 Neoplasms 1 Myofibroma 1 Lung Neoplasms 1 Liver Neoplasms 1 Endometrial Neoplasms 1 Brain Neoplasms 1 Agnosia 1

Interventions

Paclitaxel 23 Carboplatin 22 pembrolizumab 19 liposomal doxorubicin 10 Cisplatin 10 Bevacizumab 10 Gemcitabine 8 Cyclophosphamide 8 Radiotherapy 7 Blood Specimen Collection 7 olaparib 6 Topotecan 6 Nivolumab 6 Drug Therapy 6 Therapeutics 5 Doxorubicin 5 pertuzumab 4 pazopanib 4 lenvatinib 4 fludarabine 4 Trastuzumab 4 Surveys and Questionnaires 4 Dexamethasone 4 Capecitabine 4 Brachytherapy 4 palbociclib 3 mirvetuximab soravtansine 3 budigalimab 3 atezolizumab 3 Psychiatric Rehabilitation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡